BusinessPure Spectrum CBD 2018 Revenue Goal in Q1, Spearheads Return of U.S. Hemp with Turn-Key ServicesBy Nasdaq OMXMar 29, 2018, 4:23 PM UTC
BusinessPremier Biomedical Inc., CEO William Hartman Returns to Uptick Newswire’s “Stock Day” with Everett JollyBy Nasdaq OMXFeb 21, 2018, 1:00 PM UTC
BusinessAnti-Aging Patent Application Filed; Exclusive Commercial Rights to Premier Biomedical, Inc.By Nasdaq OMXFeb 12, 2018, 3:00 PM UTC
BusinessICYMI - Premier Biomedical CEO Interviewed on Fox Business “New To The Street” ProgramBy Nasdaq OMXFeb 5, 2018, 1:21 PM UTC
BusinessPremier Biomedical Updates “Stock Day” Listeners on 2017 Accomplishments; Sketches Outline Towards $5 Billion CBD Oil Market PenetrationBy Nasdaq OMXJan 17, 2018, 3:31 PM UTC
BusinessUptick Newswire “Stock Day” Interviews Dr. Bruck with Hemp Inc. and the Educational Side of the Hemp IndustryBy Nasdaq OMXJan 8, 2018, 1:01 PM UTC
BusinessUptick Newswire “Stock Day” Interviews CEO of Lexaria on Cannabis Related Products and Recent Bioscience PatentsBy Nasdaq OMXDec 18, 2017, 1:01 PM UTC
BusinessPremier Biomedical Appoints Carl Eller, NFL Retired Players Association President, as Marketing & Planning Vice-PresidentBy Nasdaq OMXNov 16, 2017, 3:00 PM UTC
